60 results
Page 3 of 3
F-1
2er2m7
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
EX-10.13
2opv3ci00 m5ji
24 Jun 19
Registration statement (foreign)
4:04pm
6-K
EX-99.1
e7cikn
5 Jun 19
Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer
2:43pm
6-K
EX-99.1
8op1r711uelp m7e
7 May 19
Current report (foreign)
1:57pm
6-K
EX-99.3
p8b1yf abruoe
7 May 19
Current report (foreign)
1:57pm
6-K
EX-99.1
qwujyng op
21 Mar 19
Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
5:23pm
20-F
EX-4.13
7pfd7
25 Feb 19
Annual report (foreign)
5:08pm
20-F
g7f5uhvxi qt
25 Feb 19
Annual report (foreign)
5:08pm
6-K
EX-99.1
3hu72m38 jk
25 Feb 19
Gamida Cell Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
4:15pm
6-K
EX-99.1
62d03dg779j692n
21 Feb 19
Current report (foreign)
2:06pm
6-K
EX-99.1
mmxjimqsh6htk6
19 Feb 19
Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells
2:05pm
DRS
v5h9ck
15 Feb 19
Draft registration statement
12:00am
6-K
EX-99.1
bgpy1kep44a1w
8 Feb 19
Current report (foreign)
9:50am
6-K
EX-99.1
yo4obybkl
25 Jan 19
Gamida Cell Announces Data from NAM-NK and NiCord® Programs to Be Presented at 2019 TCT Annual Meeting
12:22pm
6-K
EX-99.1
9z99j
7 Jan 19
Gamida Cell Announces 2019 Goals and Provides Company Update
4:25pm
424B4
x49jf7l jxjhi7e
30 Oct 18
Prospectus supplement with pricing info
8:35am
F-1/A
qpytyly2
17 Oct 18
Registration statement (foreign) (amended)
6:06am
F-1
5tfnuby
28 Sep 18
Registration statement (foreign)
4:29pm
DRS/A
aa63k9bjefmg8xemnun
3 Jul 18
Draft registration statement (amended)
12:00am
DRS
9dg hd4mrmmzuo4ch9vz
1 Jun 18
Draft registration statement
12:00am